Journal Articles

CMAJ - May 04, 2020
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence based guideline
Z. Ye, et. al.
NIH - April 20, 2020
NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
R. Gulick, H. Lane, H. Masur, et. al.
IDSA - April 11, 2020
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
A. Bhimraj, et. al.
ICM - Mar 28, 2020
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).
W. Alhazzani, et. al.
JAMA - Mar 11, 2020
Care for Critically Ill Patients With COVID-19
S. Murthy, et. al.
Potential Therapies
NEJM - May 22, 2020
Remdesivir for the Treatment of Covid-19 — Preliminary Report
JH Beigel, et. al.
Consider also:
PulmCrit - May 23, 2020
PulmCrit – Preliminary report on NIAID trial of remdesivir (ACTT-1)
Josh Farkas
Lancet - April 29, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Y. Wang, et. al.
Consider also:
PulmCrit - April 30, 2020
PulmCrit – First placebo-controlled RCT on remdesivir for COVID-19
Josh Farkas
medRxiv - April 14, 2020
Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial
W. Tang, et. al.
Consider also:
PulmCrit - April 16, 2020
PulmCrit – Hydroxychloroquine fails first meaningful RCT
Josh Farkas
NEJM - April 10, 2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein, et. al.
Consider also:
PulmCrit - April 11, 2020
PulmCrit – Eleven reasons the NEJM paper on remdesivir reveals nothing
Josh Farkas
NEJM - March 18, 2020
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao, et. al.
ICM - April 23, 2020
Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection
MC. Copin, et. al.
JAMA - March 4, 2020
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
SWX. Ong, et. al.
Case Reports/Case Series
JAMA - April 22, 2020
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
S. Richardson, et. al.
NEJM - April 17, 2020
Clinical Characteristics of Covid-19 in New York City (Correspondence)
P. Goyal, et. al.
Resuscitation - April 6, 2020
In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China
F. Shao, et. al.
JAMA - April 6, 2020
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
G. Grasselli, et. al.
Lancet - Mar 28, 2020
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
F. Zhou, et. al.
NEJM - Feb 28, 2020
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan, et. al.

Updated May 6, 2020